Hormone replacement therapy in postmenopausal asthmatic women

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 6, 2000, Pages 461-466

  Kos Kudla B ^a   Ostrowska, Z ^a   Marek, B ^a   Ciesielska Kopacz, N ^a   Sieminska, L ^a   Kajdaniuk, D ^a   Nowak, M ^a   Kudla, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bronchial asthma; Circadian rhythm; Hormone replacement therapy; Oestradiol; Oestrone

Indexed keywords

ESTRADIOL; ESTRONE; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; ASTHMA; CIRCADIAN RHYTHM; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; SYMPTOMATOLOGY;

AGED; ASTHMA; ENDOCRINE SYSTEM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; RADIOIMMUNOASSAY;

EID: 0034531034     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00310.x     Document Type: Article

References (20)

1. Low and conventional dose transdermal estradiol are equally effective at preventing bone loss in spine and femur at all postmenopausal ages
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
3. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women
4. Effect of oestrogen during menopause on risk and age at onset alzheimer's disease
5. Bronchospasm secondary to replacement estrogen therapy
6. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women?
7. Treating patients with asthma who are dependent on systemic steroids
8. Neuroendocrine and clinical effects of transdermal 17β-estradiol in postmenopausal women
9. Circadian system phase as an aspect of temporal morphology: Procedure and illustrative examples
10. Decreased adrenal sex steroid levels in the absence of glucocorticoid suppression in postmenopausal asthmatic women
11. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects
12. Lack of diurnal variation in plasma level of androstendione, testosterone, estrone and estradiol in postmenopausal women
13. Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy
14. The hormonal activity of the postmenopausal ovary
15. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens
16. Menstrual asthma: Use of a gonadotropin-releasing hormone analogue for treatment of cyclic aggravation of bronchial asthma
17. Respiratory system function in postmenopausal asthmatic women with hormone replacement therapy
18. Transdermal estradiol. A potentially improved method of hormone replacement
19. Clinical experience with Systen, a new transdermal form of hormone replacement therapy